Daré Bioscience, Inc. ( DARE) Q1 2026 Earnings Call May 14, 2026 4:30 PM EDT [Operator Instructions] We will take our first question from the line of Kemp Dolliver from Brookline Capital Markets.
Company Highlights Second Positive DSMB Review of Interim Data from Ovaprene® Phase 3 Clinical Trial, DARE to PLAY™ Anticipated Dispensing ...
Supreme Group, the first AI-native commercialization partner for healthcare and life sciences, today announced the launch of ...
Q1 2026 Earnings Call May 14, 2026 4:30 PM EDTCompany ParticipantsCraig Shesky - Chief Financial OfficerGerard Barron ...
Investor's Business Daily on MSN
When Gerry Rubin brainstorms — the biological world feels the jolt
One way to become a famous biologist is to veg out in elementary school. That's the unlikely path of Gerald Rubin.
MarketBeat on MSN
Fermi Q1 earnings call highlights
Fermi (NASDAQ:FRMI) executives used the company's first-quarter 2026 earnings call to outline a reset of its leadership ...
Dollar DOE Loan Commitments; Calumet (NASDAQ:CLMT) executives told investors the company entered 2026 facing unusually strong margin conditions ...
Company plans to submit a Biologics License Application (BLA) for aglatimagene besadenovec (aglatimagene or CAN-2409) in localized, intermediate- ...
Featured images by the Wisconsin State Journal's photo team of Amber Arnold, John Hart and Owen Ziliak.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results